Significant Drop In Deaths, Limited Harm And Reasonable Costs Shown By 20-Year Result
 

Results from one of the longest-running national breast cancer screening programmes have shown that it has contributed to a drop in deaths from the disease, that any harm caused by the screening, such as false positives and over-diagnosis, has been limited, and that the costs have been reasonable...

More...